EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Risk of opioid overdose associated with concurrent use of hydrocodone and CYP3A4-inhibiting calcium channel blockers: a population-based cohort study

Sungho Bea, Christopher Andrew Basham, Heba H Edrees, Krista F Huybrechts iD, Seanna M Vine, Robert J Glynn, Brian T Bateman, Katsiaryna Bykov iD

American Journal of Epidemiology · 2025

DOI: 10.1093/aje/kwaf198 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Sungho Bea und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, …. Hauptthemen laut MEDLINE: Calcium Channel Blockers, Hydrocodone, Cytochrome P-450 CYP3A Inhibitors, Opiate Overdose. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, AHRQ HHS, Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Ko….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nondihydropyridine calcium channel blockers (CCBs), including diltiazem and verapamil, inhibit cytochrome P450 3A4 (CYP3A4), an enzyme involved in the metabolism of hydrocodone, the most commonly used opioid in the United States. This study evaluated whether concomitant use of hydrocodone with CYP3A4-inhibiting CCBs increases the risk of opioid overdose compared to use of hydrocodone with amlodipine, a CCB that does not inhibit CYP3A4. Using 3 US databases (2000-2021), two cohorts were identified: (1) hydrocodone initiation while on CCB; and (2) CCB initiation while on hydrocodone. The outcome was hospitalization or emergency department visits for opioid overdose. Propensity score matching weights were applied to balance confounders, and Cox regression estimated HRs, pooled using random-effects meta-analysis. In hydrocodone initiation cohort (mean age 61.2 years; 53.8% female), weighted incidence rates were 2.8 and 2.6 per 1000 person-years, with a weighted HR of 1.07 (95% CI, 0.90-1.29). In CCB initiation cohort (mean age 55.2 years; 59.9% female), weighted incidence rates were 6.5 and 6.0, yielding an HR of 1.08 (95% CI, 0.88-1.32). The pooled HR was 1.07 (95% CI, 0.94-1.23). Concomitant use of hydrocodone with CYP3A4-inhibiting CCBs was not associated with an increased risk of opioid overdose relative to amlodipine. Trial registration: Real World Evidence Registry- https://osf.io/ybdt5

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcium Channel BlockersHydrocodoneCytochrome P-450 CYP3A InhibitorsOpiate OverdoseAnalgesics, OpioidHumansFemaleMaleMiddle AgedUnited StatesAgedAmlodipineAdultCohort StudiesCytochrome P-450 CYP3A

Stichwörter der Autor:innen

calcium channel blockersdrug-drug interactionhydrocodoneopioid overdosepharmacoepidemiologypopulation-based cohort study

Substanzen

Calcium Channel BlockersHydrocodoneCytochrome P-450 CYP3A InhibitorsAnalgesics, OpioidAmlodipineCytochrome P-450 CYP3ACYP3A4 protein, human

Autor:innen und Institutionen

  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
  • School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
  • Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, United States.

ORCID-Profile: Krista F Huybrechts, Katsiaryna Bykov

Förderung

  • NIA NIH HHS
  • AHRQ HHS
  • Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Ko…
  • National Institute of Health
  • Agency for Healthcare Research and Quality, US Department of Health and Human Services

Zitieren

APA

Bea, S., Basham, C. A., Edrees, H. H., Huybrechts, K. F., Vine, S. M., Glynn, R. J., Bateman, B. T., & Bykov, K. (2025). Risk of opioid overdose associated with concurrent use of hydrocodone and CYP3A4-inhibiting calcium channel blockers: a population-based cohort study. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwaf198

Vancouver

Bea S, Basham CA, Edrees HH, Huybrechts KF, Vine SM, Glynn RJ, et al. Risk of opioid overdose associated with concurrent use of hydrocodone and CYP3A4-inhibiting calcium channel blockers: a population-based cohort study. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwaf198

BibTeX
@article{Bea2025,
  author = {Bea, Sungho and Basham, Christopher Andrew and Edrees, Heba H and Huybrechts, Krista F and Vine, Seanna M and Glynn, Robert J and Bateman, Brian T and Bykov, Katsiaryna},
  title = {Risk of opioid overdose associated with concurrent use of hydrocodone and CYP3A4-inhibiting calcium channel blockers: a population-based cohort study},
  journal = {American Journal of Epidemiology},
  year = {2025},
  doi = {10.1093/aje/kwaf198}
}
Kostenlos starten →